首页 > 市场调查报告书 > 製药

感染疾病

市场调查报告书

商品编码

1812491

抗真菌药物市场：按药物类型、适应症、剂型、分销管道和地区划分

Anti Fungal Drugs Market, By Drug Type, By Indication, By Dosage Form, By Distribution Channel, By Geography

出版日期: 2025年08月20日 | 出版商:

Coherent Market Insights | 英文 164 Pages | 商品交期: 2-3个工作天内

价格

简介目录

抗真菌药物市场规模预计在 2025 年达到 150 亿美元，预计到 2032 年将达到 190.8 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 3.5%。

分析范围		分析详细信息
基准年	2024	市场规模（2025年）	150亿美元
效能数据	2020-2024	预测期	2025-2032
预测期内的复合年增长率（2025-2032）	3.50%	预计金额（2032年）	190.8亿美元

抗真菌药物用于治疗个别真菌感染疾病。常见的真菌感染疾病，例如甲真菌感染疾病和癣，通常发生在身体外部，而某些侵袭性真菌感染疾病则发生在身体组织或内臟器官内，例如肺和脑。真菌感染疾病通常更常见于免疫力较弱的人群，例如爱滋病毒/爱滋病患者。接受化疗的患者也更容易受到侵袭性真菌感染。抗真菌药物物透过杀死真菌细胞或抑制其生长发挥作用。抗真菌药物抗真菌药物、口服抗真菌药物、静脉注射抗真菌药物及阴道抗霉菌药栓。

市场动态

市场主要企业正专注于建立合作伙伴关係和签订协议等成长策略，以提升其市场影响力。例如，2017年6月，生物製药公司巴塞利亚製药有限公司（Basilea Pharmaceutica Ltd.）与辉瑞公司（Pfizer, Inc.）和阿维尔製药公司（Avir Pharma, Inc.）签署了一项协议，获得了抗真菌药物巴塞利亚的分销权。辉瑞将在俄罗斯、以色列、欧洲（北欧除外）和土耳其等地区生产和分销该药物，用于治疗危及生命的侵袭性真菌感染疾病。

同样，市场主要参与者正专注于各种商业策略，例如研发，以扩大产品系列。预计药物开发的不断增加将推动该市场的成长。例如，2019年1月，生物技术公司SCYNEXIS, Inc.宣布其正在进行的FURI试验的首次中期疗效分析取得了积极的中期结果。这项新的治疗进展适用于抗真菌治疗。

本报告的主要特点

本报告对全球抗真菌药物市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和復合年增长率。
它还强调了每个细分市场中的潜在商机，并描述了该市场的一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球抗真菌药物市场的主要企业已根据以下参数进行分析，例如公司概况、产品系列、主要亮点、财务绩效和策略。
本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
《全球抗真菌药物市场》报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过用于分析全球抗真菌药物市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 15 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	3.50%	2032 Value Projection:	USD 19.08 Bn

Antifungal drugs are used to treat fungal infections in individuals. Common fungal infections such as fungal nail infection, and ringworm etc. usually occur on the external surface of the body, while certain invasive fungal infections occur inside the body tissues or inside internal organs such as lungs and brain. Fungal infection is usually associated with individuals having weak immune system, such as people suffering from HIV/AIDS. Moreover, patients undergoing chemotherapy are susceptible to invasive fungal infections. Antifungal drugs act against the fungal infections by either killing the fungal cells or by inhibiting their growth. Antifungal drugs are broadly classified as topical antifungals, oral antifungals, intravenous antifungals, and intravaginal antifungal pessaries.

Market Dynamics

Major players in the market are focused on growth strategies such as collaborations and agreements in order to enhance their market presence. For instance, in June 2017, Basilea Pharmaceutica Ltd., a biopharmaceutical company, entered into an agreement with Pfizer, Inc. and Avir Pharma, Inc. for the distribution rights of Beasilea's antifungal treatments. Pfizer will manufacture and distribute drugs for the treatment of life-threatening invasive mold infections in regions like Russia, Israel, Europe (excluding Nordics), and Turkey.

Similarly, key players in the market are focused on various business strategies such as research and development in order to expand their product portfolio. Increasing drug development is expected to drive growth of this market. For instance, in January 2019, SCYNEXIS, Inc., a biotechnology company, announced positive interim result from their first interim efficiency analysis of an ongoing FURI study. The development of this novel treatment is indicated for antifungal treatment.

Key features of the study

This report provides an in-depth analysis of global antifungal drugs market, provides market size (USD Bn), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
It profiles leading players in the global antifungal drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A., and Astellas Pharma, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
The global antifungal drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antifungal drugs market.

Market Segmentation

By Drug Type
- Echinocandins
- Polyenes
- Allylamines
- Azoles
- Others
By Application
- Neurosurgery
- Plastic Surgery
- Cardiovascular Surgery
- Obstetrics & Gynecology
- Others
By Indication
- Aspergillosis
- Dermatophytosis
- Candidiasis
- Mucormycosis
- Others
By Dosage Form
- Powders
- Ointments
- Injections
- Tablets
- Others
By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline Plc
- Bayer AG
- Abbott Laboratories
- Merck & Co., Inc.
- Glenmark Pharmaceuticals Limited
- Enzon Pharmaceuticals, Inc.
- Pfizer Inc.
- Gilead Sciences, Inc.
- Sanofi S.A.
- Astellas Pharma, Inc.
- Alembic Pharmaceuticals Limited
- SCYNEXIS, Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Anti Fungal Drugs Market, By Drug Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Echinocandins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Polyenes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Allylamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Azoles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends

5. Global Anti Fungal Drugs Market, By Indication, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Aspergillosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Dermatophytosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Candidiasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Mucormycosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends

6. Global Anti Fungal Drugs Market, By Dosage Form, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Powders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

7. Global Anti Fungal Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

8. Global Anti Fungal Drugs Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- GlaxoSmithKline Plc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bayer AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott Laboratories
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Merck & Co., Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Glenmark Pharmaceuticals Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Enzon Pharmaceuticals, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Gilead Sciences, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sanofi S.A.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Astellas Pharma, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Alembic Pharmaceuticals Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- SCYNEXIS, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

10. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

抗真菌药物市场：按药物类型、适应症、剂型、分销管道和地区划分